Recombinant Mycobacterium bovis UPF0233 membrane protein JTY_0011 (UniProt ID: C1AJ08) is a bioengineered variant of the native protein encoded by the crgA gene in M. bovis. This hydrophobic, full-length membrane protein (93 amino acids) is expressed in E. coli and tagged with a polyhistidine sequence for purification . It belongs to the UPF0233 family of uncharacterized proteins and is classified as a cell division protein (CrgA) . While its exact biological function remains under investigation, its membrane localization and association with bacterial cell processes suggest roles in structural integrity, division, or host-pathogen interactions .
The recombinant protein is produced via bacterial expression systems, typically in E. coli, with purification achieved through affinity chromatography due to its His-tag . Challenges in solubility or folding are mitigated by optimizing buffer conditions (e.g., Tris/PBS-based buffers with 6% trehalose) and avoiding repeated freeze-thaw cycles . For large-scale applications, strategies such as concatenation of ORFs or fusion with solubility-enhancing tags (e.g., GFP, GB1) may improve yield, though these methods are not explicitly documented for JTY_0011 .
JTY_0011 is hypothesized to participate in bacterial cell division or membrane organization, given its classification as a "cell division protein" . M. bovis shares >99.95% genomic identity with Mycobacterium tuberculosis, but key differences (e.g., pyrazinamide resistance due to pncA mutations) highlight divergent pathogenic traits . While JTY_0011’s function is not directly studied, membrane proteins in M. bovis are critical for host interaction, immune evasion, and structural stability .
| Feature | M. bovis AF2122/97 | M. tuberculosis H37Rv | M. tuberculosis CDC1551 |
|---|---|---|---|
| Genome Size | 4,345,492 bp | 4,411,532 bp | 4,403,836 bp |
| Protein-Coding Genes | 3,951 | 3,995 | 4,249 |
| SNPs vs. M. tuberculosis | 2,437 (H37Rv) | – | – |
JTY_0011’s sequence homology to M. tuberculosis proteins may indicate conserved roles in mycobacterial survival .
KEGG: mbt:JTY_0011
Recombinant JTY_0011 protein is typically expressed in E. coli expression systems with an N-terminal His-tag to facilitate purification. The expression methodology involves:
Cloning the JTY_0011 gene (crgA) into an appropriate expression vector
Transforming the construct into a compatible E. coli strain
Inducing protein expression under optimized conditions
Harvesting cells and lysing to release the protein
Purifying via affinity chromatography using the His-tag
The purified protein is often provided as a lyophilized powder with greater than 90% purity as determined by SDS-PAGE. For storage, it is recommended to reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL and add 5-50% glycerol before aliquoting for long-term storage at -20°C/-80°C .
The optimal storage conditions for recombinant JTY_0011 protein are:
| Storage Parameter | Recommended Condition |
|---|---|
| Long-term storage | -20°C/-80°C in aliquots |
| Buffer composition | Tris/PBS-based buffer, 6% Trehalose, pH 8.0 |
| Preparation | Brief centrifugation prior to opening |
| Reconstitution | Deionized sterile water to 0.1-1.0 mg/mL |
| Stabilizer | 5-50% glycerol (final concentration) |
| Working aliquots | 4°C for up to one week |
It is important to avoid repeated freeze-thaw cycles as they can compromise protein integrity and activity. Centrifuging vials before opening ensures the contents are at the bottom of the tube. The addition of glycerol helps prevent protein denaturation during freezing .
To investigate JTY_0011's role in membrane protein biogenesis, researchers should consider a multifaceted experimental approach:
Gene knockout/knockdown studies:
CRISPR-Cas9 or antisense RNA techniques to downregulate JTY_0011 expression
Phenotypic analysis focusing on membrane integrity and cell division
Complementation studies with wild-type and mutant JTY_0011 variants
Protein-protein interaction studies:
Co-immunoprecipitation with potential interacting partners
Bacterial two-hybrid screening
Cross-linking studies followed by mass spectrometry
Localization studies:
Fluorescent protein tagging to determine subcellular localization
Immunoelectron microscopy to precisely locate the protein within the membrane
Functional reconstitution:
Incorporation of purified JTY_0011 into liposomes
Measuring membrane insertion/translocation activities
Since membrane protein biogenesis often involves the Oxa1 and SecY family proteins, experiments should be designed to test whether JTY_0011 interacts with these pathways. The relatively short transmembrane domains of JTY_0011 suggest it might utilize the Oxa1 family for insertion rather than the SecY channel, which typically handles membrane proteins with longer translocated segments .
When encountering contradictory data regarding JTY_0011 function, researchers should employ the following methodological approaches:
Context analysis:
Carefully evaluate experimental conditions across studies (expression systems, buffer compositions, assay temperatures)
Consider strain-specific differences in M. bovis isolates
Assess whether His-tagging or other modifications might affect function in different experimental setups
Cross-validation with multiple techniques:
Employ orthogonal methods to test the same hypothesis
Confirm protein-protein interactions using at least three independent methods
Validate functional assays with both in vitro and in vivo approaches
Statistical rigor:
Apply appropriate statistical tests, controlling for multiple comparisons
Consider Bayesian approaches to reconcile contradictory evidence
Use meta-analytical techniques when sufficient studies are available
Experimental design optimization:
Collaborative confirmation:
Establish inter-laboratory validation protocols
Share reagents and standardized protocols to reduce technical variability
When contradictions persist, they often signal previously unrecognized complexity in the system under study, potentially leading to novel discoveries about JTY_0011's context-dependent functions.
JTY_0011's interactions with other mycobacterial membrane proteins during co-translational insertion likely follow these mechanistic principles:
Ribosome-membrane association:
Sequential insertion pathway:
Potential interacting partners:
| Protein Family | Likely Interaction | Functional Significance |
|---|---|---|
| Oxa1 family | Direct interaction | Insertion of TMDs with short translocated segments |
| SRP components | Indirect association | Targeting of nascent proteins to the membrane |
| SecY complex | Possible crosstalk | Handoff of substrates between insertion pathways |
Regulatory role:
As a cell division protein (CrgA), JTY_0011 might coordinate membrane protein insertion with cell division events
It may regulate the spatial distribution of newly inserted membrane proteins relative to the division site
Experimental approaches to investigate these interactions should include in vitro reconstitution of the insertion machinery, real-time fluorescence microscopy to track protein movement, and cryo-electron microscopy to visualize the structural complexes formed during co-translational insertion.
To evaluate JTY_0011's potential role in mycobacterial pathogenicity, researchers should implement the following experimental designs:
Comparative genomics and transcriptomics:
Compare JTY_0011 sequence and expression levels between pathogenic and non-pathogenic mycobacterial strains
Analyze JTY_0011 expression changes during infection using RNA-seq data
In vitro infection models:
Animal model studies:
Use the Solomon four-group design to control for testing effects :
| Group | Pretest | Treatment | Posttest |
|---|---|---|---|
| R1 | O | X | O |
| R2 | O | - | O |
| R3 | - | X | O |
| R4 | - | - | O |
Where R = randomization, O = observation, X = infection with wild-type or modified strain
Compare bacterial burden, histopathology, and survival rates between animals infected with wild-type versus JTY_0011-modified strains
Immune response evaluation:
Structural biology approaches:
Determine if JTY_0011 structural features facilitate host-pathogen interactions
Investigate potential binding to host receptors or immune components
Optimizing expression systems for functional studies of JTY_0011 requires careful consideration of several parameters:
Expression host selection:
E. coli-based systems offer simplicity but may not provide the proper membrane environment
Mycobacterial expression hosts (M. smegmatis) provide more native-like conditions
Comparative expression in both systems can reveal host-specific effects
Vector design considerations:
| Feature | Recommendation | Rationale |
|---|---|---|
| Promoter | Inducible (e.g., T7, tetracycline-responsive) | Allows tight control over expression timing and level |
| Fusion tags | C-terminal His-tag or split tags | N-terminal tags may interfere with membrane insertion |
| Solubility enhancers | Fusion with MBP or SUMO | May improve solubility of difficult-to-express constructs |
| Cleavage sites | TEV or PreScission protease sites | Allows tag removal with minimal residual amino acids |
Expression optimization protocol:
Test multiple growth temperatures (18°C, 25°C, 30°C, 37°C)
Vary induction timing (early, mid, late log phase)
Optimize inducer concentration through titration experiments
Consider specialized media formulations for membrane protein expression
Solubilization and purification strategies:
Screen multiple detergents (DDM, LDAO, Triton X-100) for efficient extraction
Compare gentle solubilization (native conditions) versus denaturing/refolding approaches
Implement multi-step purification (affinity, ion exchange, size exclusion)
Validate proper folding through circular dichroism or limited proteolysis
Functional validation:
Develop activity assays specific to hypothesized JTY_0011 functions
Include positive and negative controls in all functional assessments
Confirm membrane localization through fractionation experiments
By systematically optimizing these parameters, researchers can produce JTY_0011 protein suitable for downstream functional characterization while minimizing artifacts associated with heterologous expression.
Studying JTY_0011 interactions with membrane lipids requires specialized analytical techniques that can probe protein-lipid interactions while maintaining a native-like membrane environment:
Liposome-based binding assays:
Prepare liposomes with defined lipid compositions mimicking mycobacterial membranes
Measure JTY_0011 binding using:
Co-flotation assays with density gradient centrifugation
Surface plasmon resonance with immobilized liposomes
Microscale thermophoresis for binding kinetics
Biophysical characterization:
Differential scanning calorimetry to detect lipid phase transitions altered by protein binding
Fluorescence anisotropy with labeled lipids to measure membrane fluidity changes
Solid-state NMR to determine specific lipid-protein contacts
Advanced microscopy techniques:
| Technique | Application | Advantage |
|---|---|---|
| Atomic force microscopy | Topographical imaging of protein in membranes | Direct visualization of protein organization |
| Cryo-electron microscopy | Structural analysis in membrane environment | Near-native conditions with minimal artifacts |
| FRET microscopy | Measure protein-lipid proximity | Dynamic measurements in real-time |
Lipid specificity profiling:
Lipid overlay assays to screen for specific lipid binding partners
Lipidomics analysis of co-purifying lipids with JTY_0011
Competition binding assays to determine relative affinities
Molecular dynamics simulations:
In silico modeling of JTY_0011-lipid interactions
Prediction of lipid binding sites and energetics
Generation of testable hypotheses for experimental validation
Crosslinking approaches:
Photoactivatable lipid analogs to capture transient interactions
Mass spectrometry identification of crosslinked residues
Mapping of lipid interaction surfaces
By combining multiple analytical approaches, researchers can build a comprehensive understanding of how JTY_0011 interacts with membrane lipids, potentially revealing important functional insights about its role in mycobacterial membrane biology.
Resolving contradictory findings about JTY_0011 topology requires a systematic approach utilizing complementary experimental techniques:
Computational prediction refinement:
Apply multiple topology prediction algorithms (TMHMM, TOPCONS, Phobius)
Create a consensus model based on the outputs of different predictors
Identify regions of high confidence versus ambiguous segments
Cysteine scanning mutagenesis:
Generate a comprehensive library of single-cysteine JTY_0011 mutants
Test accessibility using membrane-impermeable thiol-reactive reagents
Compare accessibility in intact cells versus membrane preparations
Data interpretation should follow this decision matrix:
| Reactivity in Intact Cells | Reactivity in Permeabilized Cells | Interpretation |
|---|---|---|
| + | + | Extracellular/periplasmic location |
| - | + | Cytoplasmic location |
| - | - | Buried within protein or membrane |
Fusion protein reporter assays:
Create systematic N- and C-terminal fusions with dual reporters:
GFP (folds properly only in cytoplasm)
PhoA (active only in periplasm)
Quantitative measurement of both reporter activities
Iterative truncation to map internal topology transitions
Protease protection assays:
Treatment of membrane preparations with proteases
Western blot analysis with domain-specific antibodies
Mass spectrometry identification of protected fragments
Epitope insertion with immuno-detection:
Insert epitope tags (FLAG, HA, myc) at predicted loops
Differential antibody accessibility tests with and without permeabilization
Localization by immunoelectron microscopy for nanometer resolution
Cross-validation approach:
Structural biology techniques:
X-ray crystallography of purified protein (if achievable)
Cryo-EM analysis in membrane mimetics
Solid-state NMR for topology determination in native-like environments
By implementing this multi-technique approach with rigorous controls, researchers can resolve contradictory findings and establish a consensus model of JTY_0011 topology.
JTY_0011 may have significant potential in BCG vaccine development and immunological research through several mechanisms:
As an antigen carrier:
Immunomodulatory functions:
Vaccine vector engineering:
| Modification Strategy | Potential Advantage | Experimental Approach |
|---|---|---|
| JTY_0011 overexpression | Enhanced immunogenicity | Compare immune responses to wild-type vs. overexpressing strains |
| Fusion with immunodominant epitopes | Targeted immune response | Measure epitope-specific T cell activation |
| Structure-guided mutations | Optimized antigen presentation | Rational design based on membrane topology |
Safety and efficacy considerations:
Research applications:
JTY_0011 variants could serve as tools to:
Study mechanisms of cross-presentation
Investigate membrane protein trafficking in antigen-presenting cells
Develop improved adjuvant strategies for subunit vaccines
The experimental design for studying JTY_0011's role in vaccination should follow true experimental designs with proper controls and randomization to establish valid causal relationships between JTY_0011 modifications and immunological outcomes .
Characterizing the structure of JTY_0011 requires integrating multiple advanced structural biology techniques that address the challenges inherent to membrane proteins:
By integrating data from multiple techniques, researchers can overcome the challenges associated with membrane protein structural determination and build a comprehensive structural model of JTY_0011 that informs understanding of its function in mycobacterial biology.
To elucidate JTY_0011's role in mycobacterial cell division, researchers should employ a comprehensive set of methodologies spanning genetic, biochemical, and imaging approaches:
Genetic manipulation strategies:
Conditional knockdown systems (tetracycline-regulatable, CRISPRi)
CRISPR/Cas9-mediated knockout with complementation
Site-directed mutagenesis of key residues
Fluorescent protein tagging for localization
Cell division phenotype characterization:
Time-lapse microscopy with microfluidic devices
Electron microscopy to visualize septum formation
Flow cytometry to analyze DNA content and cell size
Quantitative image analysis using specialized software
Protein-protein interaction mapping:
| Method | Advantage | Application |
|---|---|---|
| Bacterial two-hybrid | In vivo screening | Identify novel interaction partners |
| Co-immunoprecipitation | Captures native complexes | Verify interactions in mycobacteria |
| BioID proximity labeling | Identifies transient interactions | Map JTY_0011's interaction network |
| FRET microscopy | Real-time dynamics | Visualize interactions during division |
Spatiotemporal dynamics:
Fluorescence recovery after photobleaching (FRAP) to measure protein mobility
Single-molecule tracking to determine diffusion properties
Correlative light and electron microscopy to integrate functional and structural data
Super-resolution microscopy (STORM, PALM) to visualize nanoscale organization
Biochemical activity characterization:
In vitro reconstitution of division complexes
ATPase/GTPase activity assays of associated division proteins
Lipid binding and membrane remodeling assays
Structural studies of JTY_0011 in complex with division partners
Systems biology approaches:
Transcriptomics of JTY_0011 mutants to identify compensatory mechanisms
Proteomics to detect changes in the divisome composition
Metabolomics to identify effects on cell wall synthesis
Network analysis to position JTY_0011 in the division pathway
Experimental design considerations:
By integrating these methodologies, researchers can build a comprehensive understanding of JTY_0011's role in mycobacterial cell division, potentially revealing new targets for antimycobacterial therapy development.
Addressing data inconsistencies in JTY_0011 functional studies requires a systematic approach to identify sources of variation and implement appropriate analytical solutions:
Source identification:
Technical variability (expression systems, purification methods, assay conditions)
Biological variability (strain differences, growth phase, media composition)
Methodological differences (detection limits, equipment sensitivity)
Data analysis approaches (normalization methods, statistical tests)
Structured analytical framework:
Implement a hierarchical experimental design to partition variance components
Distinguish between within-experiment and between-experiment variability
Apply mixed-effects statistical models to account for nested data structures
Use meta-analytical techniques to integrate findings across studies
Validation and cross-verification strategies:
| Strategy | Implementation | Outcome |
|---|---|---|
| Independent replication | Repeat key experiments in different laboratories | Confirms reproducibility |
| Orthogonal methods | Test hypotheses using different techniques | Verifies technical robustness |
| Positive/negative controls | Include established controls in all experiments | Validates assay performance |
| Dose-response relationships | Test across concentration ranges | Establishes biological relevance |
Statistical approaches for reconciling contradictions:
Bayesian analysis to incorporate prior knowledge and update with new evidence
Sensitivity analysis to assess the impact of varying assumptions
Power analysis to ensure adequate sample sizes
Non-parametric methods when distributional assumptions are violated
Systematic reporting:
Document all experimental conditions in detail
Report negative and inconclusive results alongside positive findings
Provide raw data and analysis scripts for transparency
Apply structured formats for sharing methods and materials
Collaborative resolution:
Establish consortia to standardize protocols across laboratories
Implement round-robin testing of key hypotheses
Develop common reagents and reference materials
By implementing this comprehensive approach, researchers can distinguish genuine biological complexities of JTY_0011 function from technical artifacts, leading to more robust and reproducible findings in the field.
Analyzing complex datasets from JTY_0011 experiments requires sophisticated statistical approaches tailored to the specific experimental designs and data types:
For time-series experiments:
Repeated measures ANOVA for balanced designs
Linear mixed-effects models for handling missing data
Time-series analysis techniques including:
For high-dimensional data:
Principal component analysis (PCA) for dimensionality reduction
Partial least squares (PLS) regression for linking multiple data types
Clustering methods (hierarchical, k-means, DBSCAN) for pattern identification
Random forest and other machine learning approaches for predictive modeling
For interaction network analysis:
| Method | Application | Advantage |
|---|---|---|
| Graph-theoretic metrics | Network topology characterization | Identifies key hub proteins |
| Community detection | Functional module identification | Reveals coordinated processes |
| Bayesian networks | Causal relationship inference | Models directional influences |
| Differential network analysis | Condition-specific changes | Highlights context-dependent interactions |
For multi-level experimental designs:
For integrating heterogeneous data types:
Meta-analysis techniques for combining effect sizes across studies
Bayesian data integration frameworks
Multi-block statistical methods (DIABLO, MOFA)
Network-based data integration approaches
Specialized approaches for specific data types:
Zero-inflated models for count data with excess zeros
Survival analysis for time-to-event data
Beta regression for proportion data
Circular statistics for periodic/angular measurements
Multiple testing correction:
False discovery rate (FDR) control using Benjamini-Hochberg procedure
Family-wise error rate (FWER) control using Bonferroni or Holm method
Permutation-based significance testing for complex dependencies
Implementation should include appropriate validation steps such as cross-validation, bootstrapping, or independent test sets to ensure the robustness of findings and prevent overfitting to noise in the data.